Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation

Project Information

BCSC-ST

Grant agreement ID: 745808

DOI 10.3030/745808

Project terminated on 2 June 2018

EC signature date 27 February 2017

Start date 1 March 2017

End date 28 February 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 195 454,80

EU contribution € 195 454,80

Coordinated by

UNIVERSITY OF NEWCASTLE UPON TYNE
United Kingdom

Publications

Peer reviewed articles (1)

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy

Author(s): Ruth Rodriguez-Barrueco, Erin A. Nekritz, François Bertucci, Jiyang Yu, Felix Sanchez-Garcia, Tizita Z. Zeleke, Andrej Gorbatenko, Daniel Birnbaum, Elena Ezhkova, Carlos Cordon-Cardo, Pascal Finetti, David Llobet-Navas, Jose M. Silva
Published in: Genes & Development, Issue 31/6, 2017, Page(s) 553-566, ISSN 0890-9369
Publisher: Cold Spring Harbor Laboratory Press
DOI: 10.1101/gad.292318.116